{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:12:19Z","timestamp":1788797539910,"version":"build-2803163510"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001736","name":"German-Israeli Foundation for Scientific Research and Development","doi-asserted-by":"publisher","award":["1504"],"award-info":[{"award-number":["1504"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001736","name":"German-Israeli Foundation for Scientific Research and Development","doi-asserted-by":"publisher","award":["1504"],"award-info":[{"award-number":["1504"]}],"id":[{"id":"10.13039\/501100001736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["OoR2022\/100004"],"award-info":[{"award-number":["OoR2022\/100004"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1437\/24"],"award-info":[{"award-number":["1437\/24"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007287","name":"Worldwide Cancer Research","doi-asserted-by":"publisher","award":["20-0238"],"award-info":[{"award-number":["20-0238"]}],"id":[{"id":"10.13039\/501100007287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-65091-6","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:03:36Z","timestamp":1785733416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A protein\u2013small molecule conjugate as a bispecific inhibitor of proteases implicated in cancer metastasis"],"prefix":"10.1038","volume":"16","author":[{"given":"Inbar","family":"Bahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuval","family":"Pinkert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Arbely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aubry K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7056-2418","authenticated-orcid":false,"given":"Niv","family":"Papo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"issue":"1","key":"65091_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12957-021-02478-x","volume":"20","author":"Q Li","year":"2022","unstructured":"Li, Q. et al. Prognosis and survival analysis of patients with pancreatic cancer: Retrospective experience of a single institution. World J. Surg. Oncol. 20 (1), 11 (2022).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"65091_CR2","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1038\/s41598-025-88555-7","volume":"15","author":"Y Qiu","year":"2025","unstructured":"Qiu, Y., Cao, N., Meng, D., Yuan, J. & Zhu, Y. Survival and risk factors for metastatic colorectal cancer patients with a history of prior malignancy. Sci. Rep. 15 (1), 4045 (2025).","journal-title":"Sci. Rep."},{"issue":"1","key":"65091_CR3","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12957-025-03714-4","volume":"23","author":"K Tatsuta","year":"2025","unstructured":"Tatsuta, K. et al. Updated insights into the impact of adjuvant chemotherapy on recurrence and survival after curative resection of liver or lung metastases in colorectal cancer: A rapid review and meta-analysis. World J. Surg. Oncol. 23 (1), 56 (2025).","journal-title":"World J. Surg. Oncol."},{"issue":"1","key":"65091_CR4","doi-asserted-by":"publisher","first-page":"2438173","DOI":"10.1080\/19420862.2024.2438173","volume":"16","author":"P Jung","year":"2024","unstructured":"Jung, P. et al. A TRAILR2\/CDH3 bispecific antibody demonstrates selective apoptosis and tumor regression in CDH3-positive pancreatic cancer. mAbs 16 (1), 2438173 (2024).","journal-title":"mAbs"},{"issue":"1","key":"65091_CR5","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1186\/s12885-022-10165-7","volume":"22","author":"S Hao","year":"2022","unstructured":"Hao, S. et al. Tumour inhibitory activity on pancreatic cancer by bispecific nanobody targeting PD-L1 and CXCR4. BMC Cancer. 22 (1), 1092 (2022).","journal-title":"BMC Cancer"},{"issue":"1","key":"65091_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41420-025-02652-0","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang, Y., Du, J., Cui, X., Ling, Y. & Tang, C. Development of a bispecific CDH17-GUCY2C ADC bearing the ferroptosis inducer RSL3 for the treatment of colorectal cancer. Cell. Death Discovery. 11 (1), 347 (2025).","journal-title":"Cell. Death Discovery"},{"key":"65091_CR7","doi-asserted-by":"crossref","unstructured":"Okpalanwaka, I. F. et al. A PD-L1\/CD3 bispecific antibody enhances the antitumor effects of regorafenib against colon cancer. Mol. Cancer Therapeut. OF1\u2013OF12. (2025).","DOI":"10.1158\/1535-7163.29760614"},{"key":"65091_CR8","doi-asserted-by":"crossref","unstructured":"Li, J. et al. Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors. ;604\u2013604. (2024).","DOI":"10.1200\/JCO.2024.42.3_suppl.604"},{"issue":"1","key":"65091_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa2208470","volume":"388","author":"JH Strickler","year":"2023","unstructured":"Strickler, J. H. et al. Sotorasib in KRAS p. G12C\u2013mutated advanced pancreatic cancer. N Engl. J. Med. 388 (1), 33\u201343 (2023).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"65091_CR10","doi-asserted-by":"publisher","first-page":"e2333488","DOI":"10.1001\/jamanetworkopen.2023.33488","volume":"6","author":"F Morano","year":"2023","unstructured":"Morano, F. & Pietrantonio, F. Anti\u2013Epidermal growth factor receptor maintenance therapy in metastatic colorectal Cancer\u2014Another piece to the puzzle. JAMA Netw. Open 6 (9), e2333488 (2023).","journal-title":"JAMA Netw. Open."},{"issue":"1","key":"65091_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12957-023-03222-3","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. The efficacy and safety of anti-EGFR target agents in patients with potentially resectable metastatic colorectal cancer: A meta-analysis of randomized controlled trials. World J. Surg. Oncol. 21 (1), 340 (2023).","journal-title":"World J. Surg. Oncol."},{"issue":"12","key":"65091_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/oncolo\/oyad262","volume":"28","author":"PM Kasi","year":"2023","unstructured":"Kasi, P. M., Afable, M. G., Herting, C., Lukanowski, M. & Jin, Z. Anti-EGFR antibodies in the management of advanced colorectal cancer. Oncologist 28 (12), 1034\u20131048 (2023).","journal-title":"Oncologist"},{"issue":"1","key":"65091_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41392-023-01611-4","volume":"8","author":"Y Gao","year":"2023","unstructured":"Gao, Y., Yu, L. & Miao, H. Bispecific immune molecule PD1-IL2v: A new therapeutic strategy for pancreatic ductal adenocarcinoma. Signal. Transduct. Target. Ther. 8 (1), 382 (2023).","journal-title":"Signal. Transduct. Target. Therapy"},{"issue":"23","key":"65091_CR14","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1056\/NEJMoa2308795","volume":"389","author":"MG Fakih","year":"2023","unstructured":"Fakih, M. G. et al. Sotorasib plus panitumumab in refractory colorectal cancer with mutated KRAS G12C. N Engl. J. Med. 389 (23), 2125\u20132139 (2023).","journal-title":"N Engl. J. Med."},{"issue":"1","key":"65091_CR15","doi-asserted-by":"publisher","first-page":"2303175","DOI":"10.1002\/advs.202303175","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Challenges coexist with opportunities: Spatial heterogeneity expression of PD-L1 in cancer therapy. Adv. Sci. 11 (1), 2303175 (2024).","journal-title":"Adv. Sci."},{"key":"65091_CR16","doi-asserted-by":"crossref","unstructured":"Xin, H. et al. Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance. Heliyon 9 (2). (2023).","DOI":"10.1016\/j.heliyon.2023.e13048"},{"issue":"29","key":"65091_CR17","doi-asserted-by":"publisher","first-page":"12602","DOI":"10.1039\/D1NR02083H","volume":"13","author":"S Merminod","year":"2021","unstructured":"Merminod, S., Edison, J. R., Fang, H., Hagan, M. F. & Rogers, W. B. Avidity and surface mobility in multivalent ligand\u2013receptor binding. Nanoscale 13 (29), 12602\u201312612 (2021).","journal-title":"Nanoscale"},{"key":"65091_CR18","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1182\/blood-2024-198004","volume":"144","author":"SY Lim","year":"2024","unstructured":"Lim, S. Y. et al. Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies. Blood 144, 3436 (2024).","journal-title":"Blood"},{"key":"65091_CR19","doi-asserted-by":"crossref","unstructured":"Xu, G., Hu, J., Lipowsky, R. & Weikl, T. R. Binding constants of membrane-anchored receptors and ligands: A general theory corroborated by Monte Carlo simulations. J Chem. Phys. 143(24). (2015).","DOI":"10.1063\/1.4936134"},{"key":"65091_CR20","doi-asserted-by":"crossref","unstructured":"Clendeninn, N. J. & Appelt, K. Matrix metalloproteinase inhibitors in cancer therapy. (2000).","DOI":"10.1385\/159259011X"},{"issue":"15","key":"65091_CR21","doi-asserted-by":"publisher","first-page":"12133","DOI":"10.3390\/ijms241512133","volume":"24","author":"ZA Rashid","year":"2023","unstructured":"Rashid, Z. A. & Bardaweel, S. K. Novel matrix metalloproteinase-9 (MMP-9) inhibitors in cancer treatment. Int. J. Mol. Sci. 24 (15), 12133 (2023).","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"65091_CR22","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/cancers14071847","volume":"14","author":"K Augoff","year":"2022","unstructured":"Augoff, K., Hryniewicz-Jankowska, A., Tabola, R. & Stach, K. MMP9: A tough target for targeted therapy for cancer. Cancers 14 (7), 1847 (2022).","journal-title":"Cancers"},{"issue":"11","key":"65091_CR23","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1634\/theoncologist.2020-0474","volume":"25","author":"J Bendell","year":"2020","unstructured":"Bendell, J. et al. Safety and efficacy of andecaliximab (GS-5745) plus gemcitabine and nab\u2010paclitaxel in patients with advanced pancreatic adenocarcinoma: Results from a phase I study. Oncologist 25 (11), 954\u2013962 (2020).","journal-title":"Oncologist"},{"issue":"6","key":"65091_CR24","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1111\/jcmm.14242","volume":"23","author":"N Awasthi","year":"2019","unstructured":"Awasthi, N. et al. Therapeutic efficacy of anti\u2010MMP9 antibody in combination with nab\u2010paclitaxel\u2010based chemotherapy in pre\u2010clinical models of pancreatic cancer. J. Cell. Mol. Med. 23 (6), 3878\u20133887 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"65091_CR25","doi-asserted-by":"publisher","first-page":"viii189","DOI":"10.1093\/annonc\/mdy281.113","volume":"29","author":"H Lenz","year":"2018","unstructured":"Lenz, H. et al. Results of a phase I study of andecaliximab in combination with mFOLFOX6 and bevacizumab in patients with previously untreated metastatic colorectal cancer. Ann. Oncol. 29, viii189\u2013viii190 (2018).","journal-title":"Ann. Oncol."},{"issue":"1","key":"65091_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/ijms27010225","volume":"27","author":"T Dreyer","year":"2025","unstructured":"Dreyer, T., Schuster, D., Magdolen, V. & Goettig, P. Drug discovery strategies for kallikrein-related peptidases. Int. J. Mol. Sci. 27 (1), 225 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"19","key":"65091_CR27","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.1021\/acs.jmedchem.8b01106","volume":"61","author":"E De Vita","year":"2018","unstructured":"De Vita, E. et al. Depsipeptides featuring a neutral P1 are potent inhibitors of kallikrein-related peptidase 6 with on-target cellular activity. J. Med. Chem. 61 (19), 8859\u20138874 (2018).","journal-title":"J. Med. Chem."},{"issue":"5","key":"65091_CR28","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/cells9051076","volume":"9","author":"H Laronha","year":"2020","unstructured":"Laronha, H. & Caldeira, J. Structure and function of human matrix metalloproteinases. Cells 9 (5), 1076 (2020).","journal-title":"Cells"},{"key":"65091_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.critrevonc.2019.02.010","volume":"137","author":"G Gonzalez-Avila","year":"2019","unstructured":"Gonzalez-Avila, G. et al. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer. Crit. Rev. Oncol. 137, 57\u201383 (2019).","journal-title":"Crit. Rev. Oncol."},{"key":"65091_CR30","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.2741\/1915","volume":"11","author":"CJ M","year":"2006","unstructured":"CJ M. Matrix metalloproteinases (MMPs) in health and disease: An overview. Front. Biosci. 11, 1696\u20131701 (2006).","journal-title":"Front. Biosci."},{"issue":"1","key":"65091_CR31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17 (1), 463\u2013516 (2001).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"issue":"2","key":"65091_CR32","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1515\/cclm.2011.750","volume":"50","author":"J Bayani","year":"2012","unstructured":"Bayani, J. & Diamandis, E. P. The physiology and pathobiology of human kallikrein-related peptidase 6 (KLK6). Clin. Chem. Lab. Med. 50 (2), 211\u2013233 (2012).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"11","key":"65091_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/nrc1474","volume":"4","author":"CA Borgo\u00f1o","year":"2004","unstructured":"Borgo\u00f1o, C. A. & Diamandis, E. P. The emerging roles of human tissue kallikreins in cancer. Nat. Rev. Cancer. 4 (11), 876\u2013890 (2004).","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"65091_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1515\/BC.2001.002","volume":"382","author":"J Clements","year":"2001","unstructured":"Clements, J., Hooper, J., Dong, Y. & Harvey, T. The expanded human kallikrein (KLK) gene family: Genomic organisation, tissue-specific expression and potential functions. Biol. Chem. 382 (1), 5\u201314 (2001).","journal-title":"Biol. Chem."},{"issue":"2","key":"65091_CR35","first-page":"184","volume":"22","author":"GM Yousef","year":"2001","unstructured":"Yousef, G. M. & Diamandis, E. P. The new human tissue kallikrein gene family: Structure, function, and association to disease. Endocr. Rev. 22 (2), 184\u2013204 (2001).","journal-title":"Endocr. Rev."},{"issue":"35","key":"65091_CR36","doi-asserted-by":"publisher","first-page":"25678","DOI":"10.1074\/jbc.M602372200","volume":"281","author":"M Debela","year":"2006","unstructured":"Debela, M. et al. Specificity profiling of seven human tissue kallikreins reveals individual subsite preferences. J. Biol. Chem. 281 (35), 25678\u201325688 (2006).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"65091_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1477-7819-12-24","volume":"12","author":"B Yang","year":"2014","unstructured":"Yang, B. et al. Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer. World J. Surg. Oncol. 12 (1), 24 (2014).","journal-title":"World J. Surg. Oncol."},{"issue":"7","key":"65091_CR38","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3390\/biom12071003","volume":"12","author":"H Bouzid","year":"2022","unstructured":"Bouzid, H. et al. Kallikrein-related peptidase 6 (KLK6) as a contributor toward an aggressive cancer cell phenotype: A potential role in colon cancer peritoneal metastasis. Biomolecules 12 (7), 1003 (2022).","journal-title":"Biomolecules"},{"issue":"16","key":"65091_CR39","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3390\/cancers13163969","volume":"13","author":"JB Candido","year":"2021","unstructured":"Candido, J. B. et al. Kallikrein-related peptidase 6 is associated with the tumour microenvironment of pancreatic ductal adenocarcinoma. Cancers 13 (16), 3969 (2021).","journal-title":"Cancers"},{"issue":"1","key":"65091_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","volume":"25","author":"EI Deryugina","year":"2006","unstructured":"Deryugina, E. I. & Quigley, J. P. Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev. 25 (1), 9\u201334 (2006).","journal-title":"Cancer Metastasis Rev."},{"issue":"6","key":"65091_CR41","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s13402-020-00549-x","volume":"43","author":"C Tekin","year":"2020","unstructured":"Tekin, C. et al. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cell. Oncol. 43 (6), 1161\u20131174 (2020).","journal-title":"Cell. Oncol."},{"issue":"5","key":"65091_CR42","first-page":"1997","volume":"44","author":"L Xiang","year":"2020","unstructured":"Xiang, L. et al. Antitumor effects of curcumin on the proliferation, migration and apoptosis of human colorectal carcinoma HCT-116 cells. Oncol. Rep. 44 (5), 1997\u20132008 (2020).","journal-title":"Oncol. Rep."},{"issue":"8","key":"65091_CR43","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1158\/0008-5472.CAN-07-5154","volume":"68","author":"A Guti\u00e9rrez-Fern\u00e1ndez","year":"2008","unstructured":"Guti\u00e9rrez-Fern\u00e1ndez, A. et al. Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion. Cancer Res. 68 (8), 2755\u20132763 (2008).","journal-title":"Cancer Res."},{"issue":"5","key":"65091_CR44","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.apsb.2015.07.005","volume":"5","author":"X Guan","year":"2015","unstructured":"Guan, X. Cancer metastases: Challenges and opportunities. Acta Pharm. sinica B. 5 (5), 402\u2013418 (2015).","journal-title":"Acta Pharm. sinica B"},{"issue":"16","key":"65091_CR45","doi-asserted-by":"publisher","first-page":"4679","DOI":"10.1021\/acs.jpclett.8b01991","volume":"9","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Small unnatural amino acid carried Raman tag for molecular imaging of genetically targeted proteins. J. Phys. Chem. Lett. 9 (16), 4679\u20134685 (2018).","journal-title":"J. Phys. Chem. Lett."},{"issue":"1","key":"65091_CR46","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/hsz-2012-0249","volume":"394","author":"H Yoon","year":"2013","unstructured":"Yoon, H., Blaber, S. I., Li, W., Scarisbrick, I. A. & Blaber, M. Activation profiles of human kallikrein-related peptidases by matrix metalloproteinases. Biol. Chem. 394 (1), 137\u2013147 (2013).","journal-title":"Biol. Chem."},{"issue":"2","key":"65091_CR47","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/glia.23249","volume":"66","author":"Y Bando","year":"2018","unstructured":"Bando, Y. et al. Kallikrein 6 secreted by oligodendrocytes regulates the progression of experimental autoimmune encephalomyelitis. Glia 66 (2), 359\u2013378 (2018).","journal-title":"Glia"},{"issue":"6","key":"65091_CR48","doi-asserted-by":"publisher","first-page":"188807","DOI":"10.1016\/j.bbcan.2022.188807","volume":"1877","author":"K Deepak","year":"2022","unstructured":"Deepak, K., Roy, P. K., Kola, P., Mukherjee, B. & Mandal, M. An overview of kinin mediated events in cancer progression and therapeutic applications. Biochim. et Biophys. Acta (BBA)-Reviews Cancer. 1877 (6), 188807 (2022).","journal-title":"Biochim. et Biophys. Acta (BBA)-Reviews Cancer"},{"issue":"4","key":"65091_CR49","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5230\/jgc.2018.18.e35","volume":"18","author":"S Zhu","year":"2018","unstructured":"Zhu, S., Shi, J., Zhang, S. & Li, Z. KLK6 promotes growth, migration, and invasion of gastric cancer cells. J. Gastric Cancer. 18 (4), 356\u2013367 (2018).","journal-title":"J. Gastric Cancer"},{"issue":"1","key":"65091_CR50","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/BJ20040424","volume":"386","author":"S Porter","year":"2005","unstructured":"Porter, S., Clark, I. M., Kevorkian, L. & Edwards, D. R. The ADAMTS metalloproteinases. Biochem. J. 386 (1), 15\u201327 (2005).","journal-title":"Biochem. J."},{"issue":"46","key":"65091_CR51","doi-asserted-by":"publisher","first-page":"15337","DOI":"10.1523\/JNEUROSCI.3467-10.2010","volume":"30","author":"S Rivera","year":"2010","unstructured":"Rivera, S., Khrestchatisky, M., Kaczmarek, L., Rosenberg, G. A. & Jaworski, D. M. Metzincin proteases and their inhibitors: Foes or friends in nervous system physiology? J. Neurosci. 30 (46), 15337\u201315357 (2010).","journal-title":"J. Neurosci."},{"issue":"1","key":"65091_CR52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbamcr.2010.01.003","volume":"1803","author":"K Brew","year":"2010","unstructured":"Brew, K. & Nagase, H. The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity. Biochim. et Biophys. acta (BBA)-molecular cell. Res. 1803 (1), 55\u201371 (2010).","journal-title":"Biochim. et Biophys. acta (BBA)-molecular cell. Res."},{"issue":"3","key":"65091_CR53","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3892\/ol.2013.1755","volume":"7","author":"A Di Carlo","year":"2014","unstructured":"Di Carlo, A. Matrix metalloproteinase-2 and-9 and tissue inhibitor of metalloproteinase-1 and-2 in sera and urine of patients with renal carcinoma. Oncol. Lett. 7 (3), 621\u2013626 (2014).","journal-title":"Oncol. Lett."},{"issue":"8","key":"65091_CR54","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1074\/jbc.M116.756718","volume":"292","author":"V Arkadash","year":"2017","unstructured":"Arkadash, V. et al. Development of high affinity and high specificity inhibitors of matrix metalloproteinase 14 through computational design and directed evolution. J. Biol. Chem. 292 (8), 3481\u20133495 (2017).","journal-title":"J. Biol. Chem."},{"issue":"52","key":"65091_CR55","doi-asserted-by":"publisher","first-page":"41415","DOI":"10.1074\/jbc.M006871200","volume":"275","author":"M Toth","year":"2000","unstructured":"Toth, M. et al. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (membrane type 1)-MMP-dependent activation of pro-MMP-2. J. Biol. Chem. 275 (52), 41415\u201341423 (2000).","journal-title":"J. Biol. Chem."},{"issue":"13","key":"65091_CR56","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3390\/diagnostics14131350","volume":"14","author":"C Delrue","year":"2024","unstructured":"Delrue, C. & Speeckaert, M. M. Tissue inhibitor of metalloproteinases-2 (TIMP-2) as a prognostic biomarker in acute kidney injury: A narrative review. Diagnostics 14 (13), 1350 (2024).","journal-title":"Diagnostics"},{"issue":"30","key":"65091_CR57","doi-asserted-by":"publisher","first-page":"21362","DOI":"10.1074\/jbc.274.30.21362","volume":"274","author":"PT Wingfield","year":"1999","unstructured":"Wingfield, P. T. et al. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli: Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions. J. Biol. Chem. 274 (30), 21362\u201321368 (1999).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"65091_CR58","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1042\/BCJ20180070","volume":"475","author":"I Cohen","year":"2018","unstructured":"Cohen, I. et al. Pre-equilibrium competitive library screening for tuning inhibitor association rate and specificity toward serine proteases. Biochem. J. 475 (7), 1335\u20131352 (2018).","journal-title":"Biochem. J."},{"issue":"5","key":"65091_CR59","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1021\/acs.bioconjchem.2c00059","volume":"33","author":"H Hayun","year":"2022","unstructured":"Hayun, H. et al. Bioorthogonal PEGylation prolongs the elimination half-life of N-TIMP2 while retaining MMP inhibition. Bioconjug. Chem. 33 (5), 795\u2013806 (2022).","journal-title":"Bioconjug. Chem."},{"issue":"18","key":"65091_CR60","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.3390\/molecules28186745","volume":"28","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Advances in biosynthesis of non-canonical amino acids (ncAAs) and the methods of ncAAs incorporation into proteins. Molecules 28 (18), 6745 (2023).","journal-title":"Molecules"},{"issue":"5","key":"65091_CR61","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1042\/BCJ20200628","volume":"478","author":"G Yosef","year":"2021","unstructured":"Yosef, G., Hayun, H. & Papo, N. Simultaneous targeting of CD44 and MMP9 catalytic and hemopexin domains as a therapeutic strategy. Biochem. J. 478 (5), 1139\u20131157 (2021).","journal-title":"Biochem. J."},{"issue":"8","key":"65091_CR62","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1074\/jbc.M116.756718","volume":"292","author":"V Arkadash","year":"2017","unstructured":"Arkadash, V. et al. Development of high affinity and high specificity inhibitors of matrix metalloproteinase 14 through computational design and directed evolution. J. Biol. Chem. 292 (8), 3481\u20133495 (2017).","journal-title":"J. Biol. Chem."},{"issue":"3","key":"65091_CR63","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1021\/acs.jmedchem.3c01835","volume":"67","author":"TT Dean","year":"2024","unstructured":"Dean, T. T., Jelu-Reyes, J., Allen, A. C. & Moore, T. W. Peptide\u2013drug conjugates: An emerging direction for the next generation of peptide therapeutics. J. Med. Chem. 67 (3), 1641\u20131661 (2024).","journal-title":"J. Med. Chem."},{"issue":"2","key":"65091_CR64","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3390\/pharmaceutics15020600","volume":"15","author":"E Holz","year":"2023","unstructured":"Holz, E., Darwish, M., Tesar, D. B. & Shatz-Binder, W. A review of protein-and peptide-based chemical conjugates: Past, present, and future. Pharmaceutics 15 (2), 600 (2023).","journal-title":"Pharmaceutics"},{"issue":"4","key":"65091_CR65","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5230\/jgc.2018.18.e35","volume":"18","author":"S Zhu","year":"2018","unstructured":"Zhu, S., Shi, J., Zhang, S. & Li, Z. KLK6 promotes growth, migration, and invasion of gastric cancer cells. J. Gastric Cancer. 18 (4), 356\u2013367 (2018).","journal-title":"J. Gastric Cancer"},{"issue":"1","key":"65091_CR66","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/biom15010035","volume":"15","author":"A Shoari","year":"2024","unstructured":"Shoari, A., Ashja Ardalan, A., Dimesa, A. M. & Coban, M. A. Targeting invasion: The role of MMP-2 and MMP-9 inhibition in colorectal cancer therapy. Biomolecules 15 (1), 35 (2024).","journal-title":"Biomolecules"},{"key":"65091_CR67","doi-asserted-by":"crossref","unstructured":"Toth, M., Sohail, A. & Fridman, R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatin zymography. Metastasis Res. Protocols 121\u2013135. (2012).","DOI":"10.1007\/978-1-61779-854-2_8"},{"key":"65091_CR68","doi-asserted-by":"crossref","unstructured":"Justus, C. R., Marie, M. A., Sanderlin, E. J. & Yang, L. V. Transwell in vitro cell migration and invasion assays. Cell Viability Assays: Methods Protocols. 349\u2013359. (2023).","DOI":"10.1007\/978-1-0716-3052-5_22"},{"issue":"2","key":"65091_CR69","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"C Liang","year":"2007","unstructured":"Liang, C., Park, A. Y. & Guan, J. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2 (2), 329\u2013333 (2007).","journal-title":"Nat. Protoc."},{"key":"65091_CR70","doi-asserted-by":"crossref","unstructured":"Henkhaus, R. S., Gerner, E. W. & Ignatenko, N. A. Kallikrein 6 is a mediator of K-RAS-dependent migration of colon carcinoma cells. Biol. Chem. 389 (6), 757 (2008).","DOI":"10.1515\/BC.2008.087"},{"issue":"2","key":"65091_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.200209006","volume":"160","author":"K Wolf","year":"2003","unstructured":"Wolf, K. et al. Compensation mechanism in tumor cell migration: Mesenchymal\u2013amoeboid transition after blocking of pericellular proteolysis. J. Cell. Biol. 160 (2), 267\u2013277 (2003).","journal-title":"J. Cell. Biol."},{"issue":"6","key":"65091_CR72","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s13402-020-00549-x","volume":"43","author":"C Tekin","year":"2020","unstructured":"Tekin, C. et al. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation. Cell. Oncol. 43 (6), 1161\u20131174 (2020).","journal-title":"Cell. Oncol."},{"issue":"46","key":"65091_CR73","doi-asserted-by":"publisher","first-page":"35944","DOI":"10.1074\/jbc.M109.091769","volume":"285","author":"A Dufour","year":"2010","unstructured":"Dufour, A., Zucker, S., Sampson, N. S., Kuscu, C. & Cao, J. Role of matrix metalloproteinase-9 dimers in cell migration: Design of inhibitory peptides. J. Biol. Chem. 285 (46), 35944\u201335956 (2010).","journal-title":"J. Biol. Chem."},{"issue":"14","key":"65091_CR74","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1158\/0008-5472.CAN-10-4552","volume":"71","author":"A Dufour","year":"2011","unstructured":"Dufour, A. et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. Cancer Res. 71 (14), 4977\u20134988 (2011).","journal-title":"Cancer Res."},{"issue":"1","key":"65091_CR75","first-page":"6683391","volume":"2021","author":"P Yin","year":"2021","unstructured":"Yin, P. et al. MMP-9 knockdown inhibits oral squamous cell carcinoma lymph node metastasis in the nude mouse tongue\u2010xenografted model through the RhoC\/src pathway. Anal. Cell. Pathol. 2021 (1), 6683391 (2021).","journal-title":"Anal. Cell. Pathol."},{"issue":"33","key":"65091_CR76","doi-asserted-by":"publisher","first-page":"12663","DOI":"10.1074\/jbc.RA117.000871","volume":"293","author":"A Sananes","year":"2018","unstructured":"Sananes, A. et al. A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering. J. Biol. Chem. 293 (33), 12663\u201312680 (2018).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"65091_CR77","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3892\/etm.2021.10202","volume":"22","author":"D Zhou","year":"2021","unstructured":"Zhou, D., He, Y., Li, H. & Huang, W. Silencing of kallikrein-related peptidase 6 attenuates the proliferation, migration, and invasion of gastric cancer cells through inhibition of epithelial-mesenchymal transition. Experimental Therapeutic Med. 22 (1), 770 (2021).","journal-title":"Experimental Therapeutic Med."},{"issue":"11","key":"65091_CR78","doi-asserted-by":"publisher","first-page":"107867","DOI":"10.1016\/j.jbc.2024.107867","volume":"300","author":"N Rotenberg","year":"2024","unstructured":"Rotenberg, N. et al. Engineered TIMP2 with narrow MMP-9 specificity is an effective inhibitor of invasion and proliferation of triple-negative breast cancer cells. J. Biol. Chem. 300 (11), 107867 (2024).","journal-title":"J. Biol. Chem."},{"issue":"9","key":"65091_CR79","doi-asserted-by":"publisher","first-page":"14502","DOI":"10.18632\/oncotarget.13264","volume":"8","author":"G Pampalakis","year":"2016","unstructured":"Pampalakis, G. et al. KLK6 proteolysis is implicated in the turnover and uptake of extracellular alpha-synuclein species. Oncotarget 8 (9), 14502 (2016).","journal-title":"Oncotarget"},{"issue":"17","key":"65091_CR80","doi-asserted-by":"publisher","first-page":"8198","DOI":"10.1158\/0008-5472.CAN-07-0607","volume":"67","author":"B Klucky","year":"2007","unstructured":"Klucky, B. et al. Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion. Cancer Res. 67 (17), 8198\u20138206 (2007).","journal-title":"Cancer Res."},{"issue":"16","key":"65091_CR81","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.3390\/cancers13163969","volume":"13","author":"JB Candido","year":"2021","unstructured":"Candido, J. B. et al. Kallikrein-related peptidase 6 is associated with the tumour microenvironment of pancreatic ductal adenocarcinoma. Cancers 13 (16), 3969 (2021).","journal-title":"Cancers"},{"issue":"5","key":"65091_CR82","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/bit.26226","volume":"114","author":"E Ozer","year":"2017","unstructured":"Ozer, E. et al. In vitro suppression of two different stop codons. Biotechnol. Bioeng. 114 (5), 1065\u20131073 (2017).","journal-title":"Biotechnol. Bioeng."},{"issue":"8","key":"65091_CR83","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1074\/jbc.M116.756718","volume":"292","author":"V Arkadash","year":"2017","unstructured":"Arkadash, V. et al. Development of high affinity and high specificity inhibitors of matrix metalloproteinase 14 through computational design and directed evolution. J. Biol. Chem. 292 (8), 3481\u20133495 (2017).","journal-title":"J. Biol. Chem."},{"issue":"10","key":"65091_CR84","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1042\/BJ20151410","volume":"473","author":"I Cohen","year":"2016","unstructured":"Cohen, I. et al. Combinatorial protein engineering of proteolytically resistant mesotrypsin inhibitors as candidates for cancer therapy. Biochem. J. 473 (10), 1329\u20131341 (2016).","journal-title":"Biochem. J."},{"issue":"7","key":"65091_CR85","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1074\/jbc.M708268200","volume":"283","author":"AS Moh\u2019d","year":"2008","unstructured":"Moh\u2019d, A. S., Soares, A. S., Hockla, A. & Radisky, E. S. Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin. J. Biol. Chem. 283 (7), 4115\u20134123 (2008).","journal-title":"J. Biol. Chem."},{"key":"65091_CR86","doi-asserted-by":"crossref","unstructured":"Frankowski, H., Gu, Y., Heo, J. H., Milner, R. & Del Zoppo, G. J. Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures. Astrocytes: Methods Protocols. 221\u2013233. (2011).","DOI":"10.1007\/978-1-61779-452-0_15"},{"issue":"2","key":"65091_CR87","first-page":"442","volume":"59","author":"M Tamura","year":"1999","unstructured":"Tamura, M., Gu, J., Takino, T. & Yamada, K. M. Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: Differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59 (2), 442\u2013449 (1999).","journal-title":"Cancer Res."},{"issue":"5369","key":"65091_CR88","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","volume":"280","author":"M Tamura","year":"1998","unstructured":"Tamura, M. et al. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280 (5369), 1614\u20131617 (1998).","journal-title":"Science"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65091-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65091-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T16:02:53Z","timestamp":1788796973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-65091-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":88,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["65091"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-65091-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"assertion":[{"value":"13 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27969"}}